Cargando...
β-arrestin1 at the cross-road of endothelin-1 signaling in cancer
The advent of targeted therapeutics in human cancer has begun to find novel druggable targets and, in this context, the endothelin-1 receptor (ET-1R), namely ET(A) receptor (ET(A)R) and ET(B) receptor, among the GPCR family represents a class of highly druggable molecules in cancer. ET-1R are aberra...
Guardado en:
| Publicado en: | J Exp Clin Cancer Res |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4966762/ https://ncbi.nlm.nih.gov/pubmed/27473335 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-016-0401-4 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|